相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The cancer antigenome
Bianca Heemskerk et al.
EMBO JOURNAL (2013)
Lessons Learned From Lung Cancer Genomics: The Emerging Concept of Individualized Diagnostics and Treatment
Reinhard Buettner et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Management of non-small-cell lung cancer: recent developments
Martin Reck et al.
LANCET (2013)
Surgery for NSCLC in the era of personalized medicine
Tetsuya Mitsudomi et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2013)
Primary and Acquired Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non-small Cell Lung Cancer: An Update
Ayodele Ayoola et al.
CANCER INVESTIGATION (2012)
Exploiting the Mutanome for Tumor Vaccination
John C. Castle et al.
CANCER RESEARCH (2012)
Therapeutic Cancer Vaccines: Current Status and Moving Forward
Jeffrey Schlom
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2012)
Treating ALK-positive lung cancer-early successes and future challenges
D. Ross Camidge et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2012)
High-Throughput Droplet Digital PCR System for Absolute Quantitation of DNA Copy Number
Benjamin J. Hindson et al.
ANALYTICAL CHEMISTRY (2011)
New Strategies in Overcoming Acquired Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Lung Cancer
Geoffrey R. Oxnard et al.
CLINICAL CANCER RESEARCH (2011)
Long-term follow-up of patients with resected pancreatic cancer following vaccination against mutant K-ras
Synne Weden et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Cancer immunotherapy comes of age
Ira Mellman et al.
NATURE (2011)
Altered decamer and nonamer from an HLA-A0201-restricted epitope of Survivin differentially stimulate T-cell responses in different individuals
Chantale Bernatchez et al.
VACCINE (2011)
Effects of Src inhibitors on cell growth and epidermal growth factor receptor and MET signaling in gefitinib-resistant non-small cell lung cancer cells with acquired MET amplification
Takeshi Yoshida et al.
CANCER SCIENCE (2010)
Overcoming the hurdles of randomised clinical trials of therapeutic cancer vaccines
Tetsuro Sasada et al.
EUROPEAN JOURNAL OF CANCER (2010)
Vaccine provides new hope for patients with deadly brain cancer
[Anonymous]
FUTURE NEUROLOGY (2010)
Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial
Tetsuya Mitsudomi et al.
LANCET ONCOLOGY (2010)
Gefitinib or Chemotherapy for Non-Small-Cell Lung Cancer with Mutated EGFR.
Makoto Maemondo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Immunologic Escape After Prolonged Progression-Free Survival With Epidermal Growth Factor Receptor Variant III Peptide Vaccination in Patients With Newly Diagnosed Glioblastoma
John H. Sampson et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
The Prioritization of Cancer Antigens: A National Cancer Institute Pilot Project for the Acceleration of Translational Research
Martin A. Cheever et al.
CLINICAL CANCER RESEARCH (2009)
Gefitinib or Carboplatin-Paclitaxel in Pulmonary Adenocarcinoma.
Tony S. Mok et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Activating and resistance mutations of EGFR in non-small-cell lung cancer: role in clinical response to EGFR tyrosine kinase inhibitors
A. F. Gazdar
ONCOGENE (2009)
Evaluation of MHC class I peptide binding prediction servers: Applications for vaccine research
Hong Huang Lin et al.
BMC IMMUNOLOGY (2008)
Pilot study of mutant ras peptide-based vaccine as an adjuvant treatment in pancreatic and colorectal cancers
Antoun Toubaji et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2008)
Erythropoietin-producing hepatocyte B6 variant-derived peptides with the ability to induce glioma-reactive cytotoxic T lymphocytes in human leukocyte antigen-A2+ glioma patients
Mingyue Jin et al.
CANCER SCIENCE (2008)
Molecular origins of cancer - Cancer immunology
Olivera J. Finn
NEW ENGLAND JOURNAL OF MEDICINE (2008)
A point mutation in the NFYC gene generates an antigenic peptide recognized by autologous cytolytic T lymphocytes on a human squamous cell lung carcinoma
M Takenoyama et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
The response of autologous T cells to a human melanoma is dominated by mutated neoantigens
V Lennerz et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
T cell avidity and tumor recognition: implications and therapeutic strategies
MD McKee et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2005)
Genetic heterogeneity of the epidermal growth factor receptor in non-small cell lung cancer cell lines revealed by a rapid and sensitive detection system, the peptide nucleic acid-locked nucleic acid PCR clamp
Y Nagai et al.
CANCER RESEARCH (2005)
Establishment of a human non-small cell lung cancer cell line resistant to gefitinib
F Koizumi et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Acquired resistance of lung adenocarcinomas to gefitinib or erlotinib is associated with a second mutation in the EGFR kinase domain
W Pao et al.
PLOS MEDICINE (2005)
EGFR mutation and resistance of non-small-cell lung cancer to gefitinib
S Kobayashi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Immediate early response gene X-1, a stress-inducible antiapoptotic gene, encodes cytotoxic T-lymphocyte (CTL) epitopes capable of inducing human leukocyte antigen-A33-restricted and tumor-reactive CTLs in gastric cancer patients
T Sasada et al.
CANCER RESEARCH (2004)
Simultaneous cellular and humoral immune response against mutated p53 in a patient with lung cancer
Y Ichiki et al.
JOURNAL OF IMMUNOLOGY (2004)
EGF receptor gene mutations are common in lung cancers from never smokers and are associated with sensitivity of tumors to gefitinib and erlotinib
W Pao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Cancer immunotherapy: moving beyond current vaccines
SA Rosenberg et al.
NATURE MEDICINE (2004)
EGFR mutations in lung cancer:: Correlation with clinical response to gefitinib therapy
JG Paez et al.
SCIENCE (2004)
Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib
TJ Lynch et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Majority of peptides binding HLA-A*0201 with high affinity crossreact with other A2-supertype molecules
J Sidney et al.
HUMAN IMMUNOLOGY (2001)
The structure and stability of an HLA-A*0201/octameric tax peptide complex with an empty conserved peptide-N-terminal binding site
AR Khan et al.
JOURNAL OF IMMUNOLOGY (2000)
Identification of a gene coding for a new squamous cell carcinoma antigen recognized by the CTL
M Nakao et al.
JOURNAL OF IMMUNOLOGY (2000)
分享论文
